WINDLAS BIOTECH
Back to Income Statement
|
WINDLAS BIOTECH Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹61 Cr | ₹58 Cr | ₹43 Cr | ₹38 Cr | ₹16 Cr |
What is the latest Consolidated Net Profit of WINDLAS BIOTECH ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹61 Cr |
| Mar2024 | ₹58 Cr |
| Mar2023 | ₹43 Cr |
| Mar2022 | ₹38 Cr |
| Mar2021 | ₹16 Cr |
How is Consolidated Net Profit of WINDLAS BIOTECH Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹61 Cr | 4.82 | |
| Mar2024 | ₹58 Cr | 36.51 | |
| Mar2023 | ₹43 Cr | 11.91 | |
| Mar2022 | ₹38 Cr | 140.58 | |
| Mar2021 | ₹16 Cr | - | |
Compare Consolidated Net Profit of peers of WINDLAS BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WINDLAS BIOTECH | ₹1,639.8 Cr | -0.6% | -3.5% | -30.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,708.0 Cr | -2.9% | -1.8% | -2.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,975.0 Cr | 2.1% | 0.2% | 9.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹128,619.0 Cr | 0.5% | 2.2% | 11.2% | Stock Analytics | |
| CIPLA | ₹122,539.0 Cr | 0.7% | -0.8% | 3.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,741.0 Cr | -0.1% | 2.5% | 2.5% | Stock Analytics | |
WINDLAS BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WINDLAS BIOTECH | -0.6% |
-3.5% |
-30.8% |
| SENSEX | -0.4% |
-0.3% |
3.9% |
You may also like the below Video Courses